Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.6870
+0.0020 (0.29%)
At close: Aug 6, 2026, 4:00 PM EDT
0.7030
+0.0160 (2.33%)
After-hours: Aug 6, 2026, 7:56 PM EDT
Fractyl Health Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
100
Market Cap
108.99M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 93.00K | -27.00K | -22.50% |
| Dec 31, 2023 | 120.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Black Diamond Therapeutics | 70.00M |
| Cue Biopharma | 32.73M |
| Pelthos Therapeutics | 27.70M |
| Coya Therapeutics | 7.94M |
| Rani Therapeutics Holdings | 3.17M |
GUTS News
- 3 days ago - Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026 - GlobeNewsWire
- 15 days ago - Fractyl Health to Participate in Upcoming Investor Events - GlobeNewsWire
- 22 days ago - Fractyl Health Transcript: Study result - Transcripts
- 22 days ago - Fractyl Health Press release: Study result - Filings
- 22 days ago - Fractyl Health Slides: Study result - Filings
- 22 days ago - Fractyl Health reports results from REMAIN-1 Midpoint Cohort - TheFly
- 22 days ago - Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation - GlobeNewsWire
- 5 weeks ago - Craig-Hallum bullish on Fractyl Health, initiates with a Buy - TheFly